University of Leicester
Chronic condition comorbidity and multidrug therapy in general practice populations: a cross-sectional linkage study.pdf (788.26 kB)

Chronic condition comorbidity and multidrug therapy in general practice populations: a cross-sectional linkage study.

Download (788.26 kB)
journal contribution
posted on 2019-10-22, 13:41 authored by Eyitope R. Roberts, Daniel Green, Umesh T. Kadam
OBJECTIVES: The study investigated (1) the association between comorbidity and multidrug prescribing compared with the index condition, and (2) the association between vascular comorbidity and non-vascular condition key drug prescribing. DESIGN: Cross-sectional study linking anonymised computer consultations with prescription records for a 2-year time period. SETTING: 11 general practices in North Staffordshire, England. PARTICIPANTS: Study groups aged 40 years and over (N=12 875). Within six conditions, comorbid group with the other five conditions was compared with an 'alone' group without them. Additionally, how the 'vascular' (one of diabetes, cardiovascular disease and cerebrovascular disease) comorbidity influenced chronic obstructive pulmonary disease (COPD), osteoarthritis (OA) or depression drug prescribing was investigated. OUTCOME MEASURES: Based on the British National Formulary, five main drug chapters constituted a measure of drug counts, with low count as 2 or less and high multidrug count as 3 or more. Key drugs prescribed for COPD, OA and depression were derived from guidelines. RESULTS: The adjusted associations between the comorbid groups and higher multidrug count compared with their respective 'alone' group were: odds ratio (OR) 7.1 (95% CI 5.6 to 9.0) for depression, OR 5.4 (95% CI 4.6 to 6.3) for cardiovascular disease, OR 3.7 (95% CI 2.8 to 5.0) for cerebrovascular disease, OR 3.6 (95% CI 3.1 to 4.3) for OA, OR 3.5 (95% CI 3.0 to 4.2) for diabetes and OR 3.2 (95% CI 2.6 to 4.0) for COPD. In COPD, vascular comorbidity was associated with a significant reduction in key COPD drug treatments (adjusted OR 0.6 (95% CI 0.4 to 0.8). In depression, vascular comorbidity was associated with a reduction in key depression drug treatments (OR 0.6 (95% CI 0.4 to 0.7)). CONCLUSIONS: Our findings show that multidrug prescribing for different body systems is higher with comorbidity and may be associated with lower likelihood of prescribing for specific conditions. Further research is required on whether multidrug prescribing influences the outcomes of care for chronic conditions.


This work was funded by a National Institute for Health Research (NIHR) In-Practice Fellowship for ERR and a NIHR School for Primary Care Research Doctoral Training Studentship for DJG. CiPCA and PiPCA databases were funded by the North Staffordshire Primary Care Research Consortium and Keele University Institute for Primary Care and Health Sciences. This report presents independent research commissioned by the NIHR. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.



BMJ Open 2014;4:e005429

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Health Sciences


  • VoR (Version of Record)

Published in

BMJ Open 2014;4:e005429


BMJ Publishing Group



Copyright date


Available date


Publisher version